Gilead Lifts 2020 Guidance Driven By Remdesivir Demand; Shares Gain

Retrieved on: 2021-01-11 15:53:46

Tags for this article:

Click the tags to see associated articles and topics

Gilead Lifts 2020 Guidance Driven By Remdesivir Demand; Shares Gain. View article details on hiswai:

Excerpt

Gilead Sciences raised its full-year 2020 profit forecast on Monday fueled by demand for its remdesivir treatment during the COVID-19 pandemic.

Article found on: www.smarteranalyst.com